Status:
COMPLETED
Screening for Subjects to Participate in Studies of Blood Disorders
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Bone Marrow Transplant
Sickle Cell Disease
Eligibility:
All Genders
Brief Summary
This study will determine eligibility for participation in research studies on blood disorders conducted by the National Heart, Lung and Blood Institute and the National Institute of Diabetes, Digesti...
Detailed Description
This study allows the evaluation of subjects in order to determine their ability to safely participate in other active NIH research studies studying blood disorders. This protocol serves several purpo...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Subjects will be entered on this protocol at the time of their first visit to the NIH Clinical Center outpatient clinic or inpatient service if the subject is able to give consent/assent and the subject may have a blood disorder, may be a stem cell transplant donor, or may be a healthy volunteer.
- The subject or the subject s guardian is capable of informed consent and willing to sign the consent form after initial counseling by clinical staff. Additional consent for clinically indicated procedures (central venous catheter placement; biopsy of liver, kidney; or bone marrow) or blood transfusions will be obtained.
- The subject has a reasonable likelihood of having a disorder for which MMB or MCHB has an active research protocol, and based on information received from an outside physician, he/she appears to meet at least preliminary eligibility criteria for that protocol.
- The subject has been identified as a potential donor for a subject for whom the MMB or MCHB has an active stem cell transplant protocol and based on information received from an outside physician, he/she appears to meet preliminary eligibility as a donor.
- The subject (age greater than or equal to18) is a healthy volunteer for whom the MMB or MCHB has an active study recruiting healthy normal volunteers and he/she appears to meet preliminary eligibility as a healthy volunteer.
- EXCLUSION CRITERIA:
- Unable to comprehend the investigational nature of the protocol participation
- Abnormal CBC for healthy volunteers
- Positive pregnancy test for stem cell donors and healthy volunteers
Exclusion
Key Trial Info
Start Date :
July 3 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 2 2021
Estimated Enrollment :
816 Patients enrolled
Trial Details
Trial ID
NCT00695123
Start Date
July 3 2008
End Date
April 2 2021
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892